Report highlights rising use of mental health medications in US

A report from Medco Health Solutions revealed that more than one in five adult Americans took at least one medication to treat a psychiatric or behavioural disorder in 2010. 'America's State of Mind'

Viewpoints: Finding savings in Medicare; The Avastin saga; Changes in health care business

The New York Times: Fixing Medicare There is no way to wrestle down the deficit without reining in Medicare costs. Ensuring that the program provides quality health care coverage to millions of olde

The 16th Asian Harmonization Working Party (AHWP) Meeting was held in Denpasar, Indonesia, on November 8-11, 2011. Directors and relevant officials of the Department of Medical Device Supervision and the Department of International Cooperation of the State Food and Drug Administration of China, representatives from the medical device regulatory bodies and enterprises of more than 20 member economies, as well as experts and scholars from the USA, EU, Japan, Australia and WHO, totaling more than 300 people, attended the meeting.

The 16th Asian Harmonization Working Party (AHWP) Meeting was held in Denpasar, Indonesia, on November 8-11, 2011. Directors and relevant officials of the Department of Medical Device Supervision and

Bristol-Myers Squibb and Pfizer report apixaban trial results

Bristol-Myers Squibb and Pfizer have presented the results of the Phase III trial to compare apixaban (Eliquis) to enoxaparin in acutely ill medical patients. In the study, patients randomised to api

Changing priorities for major generic drug producers could lead to rising drug prices in developing countries

This is Africa reports on how changing priorities for major generic drug producing countries, such as Brazil, India and China -- countries that "redefined affordable drugs, making access to medicines

Cancer drug joins list of medicines in short supply

Los Angeles Times: Cancer Drug Doxil Joins Growing List Of Drugs In Short Supply A crucial cancer drug has been in short supply since midsummer -; and its maker, Johnson & Johnson Inc., has not

FDA approves Acetaminophen and Codeine Phosphate Oral Solution USP, 120mg/12mg per 5mL

Qualitest Pharmaceuticals today announced that the U.S. Food and Drug Administration has approved Acetaminophen and Codeine Phosphate Oral Solution USP, 120mg/12mg per 5mL. The total sales for Acet

US drug approval rates higher than ever

Over the past 12 months, the US Food and Drug Administration (FDA) approved 35 new medicines, the second highest approval rate this decade. Amongst the approved new drugs are two lifesaving medicines

SFDA Deputy Commissioner Bian Zhenjia meets Vice Minister of Health of Vietnam

On the afternoon of November 1, 2011, Bian Zhenjia, Deputy Commissioner of the State Food and Drug Administration (SFDA), met with Mr. Cao Minh Quang, Vice Minister of Health of Vietnam, and his entou

India to extend pharmaceutical price control

India is to extend its price control of essential medicines from the current 34 to at least 400 drugs, accounting for approximately 60% of the domestic pharmaceutical market. The National Pharmaceuti